Cazitel Plus Tablets for Dogs

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

有効成分:

Praziquantel; Pyrantel embonate ; Febantel

から入手可能:

Chanelle Pharmaceuticals Manufacturing Limited

ATCコード:

QP52AA51

INN（国際名）:

Praziquantel; Pyrantel embonate ; Febantel

投薬量:

50,50,150 mg/tablet

医薬品形態:

Tablet

処方タイプ:

CAM: Companion Animal Medicine as defined in relevant national legislation

治療群:

Dogs

治療領域:

praziquantel, combinations

適応症:

Endoparasiticide

認証ステータス:

Authorised

承認日:

2009-03-20

製品の特徴

1
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cazitel Plus Tablets For Dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCES:
Praziquantel
50 mg
Pyrantel
50 mg
(equivalent to 144 mg pyrantel embonate)
Febantel
150 mg
EXCIPIENTS:
QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS
Lactose monohydrate
Microcrystalline cellulose
Magnesium stearate
Colloidal anhydrous silica
Croscarmellose sodium
Sodium laurilsulfate
Pork flavour
A pale yellow tablet with a cross breakline on one side.
The tablets can be divided into 2 or 4 equal parts.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Dogs.
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
Treatment of mixed infections by nematodes and cestodes of the
following species:
NEMATODES:
ASCARIDS:
_Toxocara canis_
,
_Toxascaris leonina_
(adult and late immature forms).
HOOKWORMS:
_Uncinaria stenocephala_
,
_Ancylostoma caninum_
(adults).
WHIPWORMS:
_Trichuris vulpis_
(adults).
CESTODES:
TAPEWORMS:
_Echinococcus_
species
_(E. granulosus, E. multilocularis), Taenia_
species
_(T. hydatigena, T. pisiformis, T. taeniformis), Dipylidium caninum_
(adult and immature forms).
3.3
CONTRAINDICATIONS
Do not use simultaneously with piperazine compounds.
Do not use in cases of hypersensitivity to the active substances or to
any of the excipients.
3.4
SPECIAL WARNINGS
2
Fleas
serve
as
intermediate
hosts
for
one
common
type
of
tapeworm
–
_Dipylidium _
_caninum_
.
Tapeworm infestation is certain to reoccur unless control of
intermediate hosts such as fleas, mice, etc.
is undertaken.
Tapeworm infestation is unlikely in pups less than 6 weeks of age.
Parasite resistance to any particular class of anthelmintic may
develop following frequent, repeated
use of an anthelmintic of that class.
Unnecessary use of antiparasitics or use deviating from the
instructions given in the SPC may increase
the resistance selection pressure and lead to reduced efficacy. The
decision to use the product should
be based on confirmation of the parasitic species and burden, or of